COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Pierre Barbery, Sophie Georgin‐Lavialle et al.|The Lancet Rheumatology|2021Cited by 292
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)Cécile Yelnik, Doruk Erkan, Zeynep Belce Erton et al.|Seminars in Arthritis and Rheumatism|2023Cited by 7